Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
AstraZeneca
Express Scripts
Cantor Fitzgerald
Healthtrust
UBS
Baxter
US Department of Justice
Merck

Generated: December 15, 2018

DrugPatentWatch Database Preview

Litigation Details for Warner Chilcott Company v. Teva Pharmaceuticals USA Inc. (D. Del. 2008)

« Back to Dashboard

Warner Chilcott Company v. Teva Pharmaceuticals USA Inc. (D. Del. 2008)

Docket ➤ Try a Free Trial Date Filed 2008-09-26
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Patents 3,962,432; 4,621,077; 4,777,163; 4,876,248; 4,927,814; 5,358,941; 5,462,932; 5,583,122; 5,622,721; 5,994,329; 6,124,314; 6,143,326; 6,165,513; 6,225,294; 6,294,196; 6,432,932; 7,192,938; 7,410,957; 7,718,634
Link to Docket External link to docket
Small Molecule Drugs cited in Warner Chilcott Company v. Teva Pharmaceuticals USA Inc.
Biologic Drugs cited in Warner Chilcott Company v. Teva Pharmaceuticals USA Inc.
The biologic drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for Warner Chilcott Company v. Teva Pharmaceuticals USA Inc. (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 106 litigation involved, infer alia, United States Patent No. 7,192,938, Which is at issue in this Action; WHEREAS…litigation involved, inter alia, United States Patent No. 7,192,938, Which is at issue in this Action; WHEREAS…26 September 2008 1:08-cv-00627-LPS Patent None District Court, D. Delaware External link to document
0000-00-00 108 litigation involved, inter alia, United States Patent No. 7,192,938, Which is at issue in this Action; WHEREAS…litigation involved, inter alia, United States Patent No. 7,192,938, which is at issue in this Action; WHEREAS…26 September 2008 1:08-cv-00627-LPS Patent None District Court, D. Delaware External link to document
0000-00-00 109 construction related to U.S. Patent No. 6,165,513 ("the '513 patent"), to be limited to issues…construction related to U.S. Patent No. 7,192,938 ("the '938 patent") with a page limit of…construction related to U.S. Patent No. 7,192,938 ("the '938 patent") with a page limit of…'938 patent to focus on developing the themes unique to that method of treatment patent. WSTO1…that are unique to Teva concerning the '513 patent (subject to ordinary page limitations under Local External link to document
0000-00-00 124 construction of certain terms of U.S. Patent No. 6,165,513 (“the ‘513 patent”), which is at issue in the Teva…Chilcott/P&G and Teva on terms from U.S, Patent No, 6,165,513 will remain unchanged.) RLFI 3711355v. … The ‘634 patent is in the same patent family as U.S. Patent No. 7,192,938 (“the ‘938 patent”), which … regard to an additional patent _ U.S. Patent No. 7,718,634 (“the ‘634 patent”) f Which Was more recently…claim construction issues on the ‘938 patent and the ‘634 patent may be addressed together. The parties External link to document
0000-00-00 129 action for patent infringement of U.S. Patent No. 5,583,122 (“the ‘122 Patent”), U.S. Patent No. 7,192,…Federal Circuit, all involving U.S. Patent No. 5,583,122 (the “’ 122 Patent”): The Procfer & Gamble CO…the ‘938 Patent”), and U.S. Patent No. 6,165,513 (“the ‘5 13 Patent”), arising under the patent laws of…the ‘122 patent Were not invalid by reason of obviousness or obviousness-type double patenting On May 23…States Patent and Trademark Office (“PTO”), WCCLLC is the owner by assignment of the ‘ 122 Patent, entitled External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Federal Trade Commission
Argus Health
Farmers Insurance
Julphar
Fuji
Healthtrust
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.